192 related articles for article (PubMed ID: 18981184)
1. Tumor suppressor SMAR1 represses IkappaBalpha expression and inhibits p65 transactivation through matrix attachment regions.
Singh K; Sinha S; Malonia SK; Bist P; Tergaonkar V; Chattopadhyay S
J Biol Chem; 2009 Jan; 284(2):1267-78. PubMed ID: 18981184
[TBL] [Abstract][Full Text] [Related]
2. Chromatin remodeling protein SMAR1 regulates NF-κB dependent Interleukin-8 transcription in breast cancer.
Malonia SK; Yadav B; Sinha S; Lazennec G; Chattopadhyay S
Int J Biochem Cell Biol; 2014 Oct; 55():220-6. PubMed ID: 25239884
[TBL] [Abstract][Full Text] [Related]
3. SMAR1 forms a ternary complex with p53-MDM2 and negatively regulates p53-mediated transcription.
Pavithra L; Mukherjee S; Sreenath K; Kar S; Sakaguchi K; Roy S; Chattopadhyay S
J Mol Biol; 2009 May; 388(4):691-702. PubMed ID: 19303885
[TBL] [Abstract][Full Text] [Related]
4. Tumor suppressor SMAR1 mediates cyclin D1 repression by recruitment of the SIN3/histone deacetylase 1 complex.
Rampalli S; Pavithra L; Bhatt A; Kundu TK; Chattopadhyay S
Mol Cell Biol; 2005 Oct; 25(19):8415-29. PubMed ID: 16166625
[TBL] [Abstract][Full Text] [Related]
5. p53 target gene SMAR1 is dysregulated in breast cancer: its role in cancer cell migration and invasion.
Singh K; Mogare D; Giridharagopalan RO; Gogiraju R; Pande G; Chattopadhyay S
PLoS One; 2007 Aug; 2(7):e660. PubMed ID: 17668048
[TBL] [Abstract][Full Text] [Related]
6. Transformation nonresponsive cells owe their resistance to lack of p65/nuclear factor-kappaB activation.
Hsu TC; Nair R; Tulsian P; Camalier CE; Hegamyer GA; Young MR; Colburn NH
Cancer Res; 2001 May; 61(10):4160-8. PubMed ID: 11358840
[TBL] [Abstract][Full Text] [Related]
7. Promoter-dependent effect of IKKalpha on NF-kappaB/p65 DNA binding.
Gloire G; Horion J; El Mjiyad N; Bex F; Chariot A; Dejardin E; Piette J
J Biol Chem; 2007 Jul; 282(29):21308-18. PubMed ID: 17537731
[TBL] [Abstract][Full Text] [Related]
8. Duration of nuclear NF-kappaB action regulated by reversible acetylation.
Chen Lf ; Fischle W; Verdin E; Greene WC
Science; 2001 Aug; 293(5535):1653-7. PubMed ID: 11533489
[TBL] [Abstract][Full Text] [Related]
9. IkappaB kinase alpha-mediated derepression of SMRT potentiates acetylation of RelA/p65 by p300.
Hoberg JE; Popko AE; Ramsey CS; Mayo MW
Mol Cell Biol; 2006 Jan; 26(2):457-71. PubMed ID: 16382138
[TBL] [Abstract][Full Text] [Related]
10. Cross talk between stimulated NF-kappaB and the tumor suppressor p53.
Schneider G; Henrich A; Greiner G; Wolf V; Lovas A; Wieczorek M; Wagner T; Reichardt S; von Werder A; Schmid RM; Weih F; Heinzel T; Saur D; Krämer OH
Oncogene; 2010 May; 29(19):2795-806. PubMed ID: 20190799
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer metastasis suppressor 1 functions as a corepressor by enhancing histone deacetylase 1-mediated deacetylation of RelA/p65 and promoting apoptosis.
Liu Y; Smith PW; Jones DR
Mol Cell Biol; 2006 Dec; 26(23):8683-96. PubMed ID: 17000776
[TBL] [Abstract][Full Text] [Related]
12. Coordinated regulation of p53 apoptotic targets BAX and PUMA by SMAR1 through an identical MAR element.
Sinha S; Malonia SK; Mittal SP; Singh K; Kadreppa S; Kamat R; Mukhopadhyaya R; Pal JK; Chattopadhyay S
EMBO J; 2010 Feb; 29(4):830-42. PubMed ID: 20075864
[TBL] [Abstract][Full Text] [Related]
13. The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression.
Ashburner BP; Westerheide SD; Baldwin AS
Mol Cell Biol; 2001 Oct; 21(20):7065-77. PubMed ID: 11564889
[TBL] [Abstract][Full Text] [Related]
14. Tumor Necrosis Factor alpha (TNFalpha) regulates CD40 expression through SMAR1 phosphorylation.
Singh K; Sinha S; Malonia SK; Chattopadhyay S
Biochem Biophys Res Commun; 2010 Jan; 391(2):1255-61. PubMed ID: 20006573
[TBL] [Abstract][Full Text] [Related]
15. Statins prevent NF-kappaB transactivation independently of the IKK-pathway in human endothelial cells.
Hölschermann H; Schuster D; Parviz B; Haberbosch W; Tillmanns H; Muth H
Atherosclerosis; 2006 Apr; 185(2):240-5. PubMed ID: 16051251
[TBL] [Abstract][Full Text] [Related]
16. BRMS1 contributes to the negative regulation of uPA gene expression through recruitment of HDAC1 to the NF-kappaB binding site of the uPA promoter.
Cicek M; Fukuyama R; Cicek MS; Sizemore S; Welch DR; Sizemore N; Casey G
Clin Exp Metastasis; 2009; 26(3):229-37. PubMed ID: 19165610
[TBL] [Abstract][Full Text] [Related]
17. Ursolic acid inhibits nuclear factor-kappaB activation induced by carcinogenic agents through suppression of IkappaBalpha kinase and p65 phosphorylation: correlation with down-regulation of cyclooxygenase 2, matrix metalloproteinase 9, and cyclin D1.
Shishodia S; Majumdar S; Banerjee S; Aggarwal BB
Cancer Res; 2003 Aug; 63(15):4375-83. PubMed ID: 12907607
[TBL] [Abstract][Full Text] [Related]
18. Yangonin blocks tumor necrosis factor-α-induced nuclear factor-κB-dependent transcription by inhibiting the transactivation potential of the RelA/p65 subunit.
Ma J; Liang H; Jin HR; Dat NT; Zhang SY; Jiang YZ; Nan JX; Li D; Wu X; Lee JJ; Jin X
J Pharmacol Sci; 2012; 118(4):447-54. PubMed ID: 22510965
[TBL] [Abstract][Full Text] [Related]
19. N-(4-hydroxyphenyl)retinamide inhibits invasion, suppresses osteoclastogenesis, and potentiates apoptosis through down-regulation of I(kappa)B(alpha) kinase and nuclear factor-kappaB-regulated gene products.
Shishodia S; Gutierrez AM; Lotan R; Aggarwal BB
Cancer Res; 2005 Oct; 65(20):9555-65. PubMed ID: 16230421
[TBL] [Abstract][Full Text] [Related]
20. 1alpha,25-Dihydroxyvitamin D3 inhibits transcriptional potential of nuclear factor kappa B in breast cancer cells.
Tse AK; Zhu GY; Wan CK; Shen XL; Yu ZL; Fong WF
Mol Immunol; 2010 May; 47(9):1728-38. PubMed ID: 20371119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
